Latest Balance Sheet News

PeopleIN Limited reported a resilient FY25 with a 6.4% revenue dip but strengthened its balance sheet through $27.45 million debt reduction and announced a $6 million on-market share buy-back.

Praemium Limited reported a robust 25% revenue increase and a 55% jump in net profit for FY2025, driven by strategic client wins and innovative product launches.

PeopleIN Limited posted a statutory net loss of $11.862 million for FY25, impacted by tough economic conditions and weather disruptions, while achieving significant cost savings and announcing a $6 million share buy-back.

Alfabs Australia Limited reported a robust 242% increase in net profit for FY2025 despite a slight dip in revenue, underpinned by strong operational performance and major contract deliveries. The company declared a final dividend, signaling confidence in its financial position.

Embark Early Education Limited reported a strong half-year performance with revenue up 43.5% and profit after tax rising 62.2%, driven by acquisitions and operational efficiencies. The company expanded its footprint with a new centre in Queensland, adding 99 childcare places.

Stanmore Resources reports a challenging first half of 2025 with lower coal prices and significant wet weather impacting production and earnings, but maintains safety excellence and cost discipline while preparing for a second-half recovery and growth projects.

Stanmore Resources delivered resilient first-half 2025 results despite severe wet weather, maintaining solid production and financial metrics while suspending its interim dividend amid economic uncertainty.

nib Holdings reported a solid FY25 with underlying operating profit of $239.2 million and 3.2% policyholder growth, driven by digital innovation and operational efficiencies. The Group’s strategic focus on core health insurance and adjacent services sets the stage for continued momentum into FY26.

Vita Life Sciences delivered a robust first half in 2025 with record revenue and profit growth, driven by strong performances in Australia and Southeast Asia. The company also raised its interim dividend and expanded marketing efforts.

Vita Life Sciences reported a robust half-year performance with revenue up 15.4% to A$45.5 million and a 12.2% rise in net profit, driven by strong growth in Australia and Southeast Asia. The company also increased its interim dividend to 4.5 cents per share, signaling confidence despite challenges in China.

Pilbara Minerals reported a 4% increase in lithium production for FY25 despite a 39% revenue drop amid falling prices, maintaining a robust balance sheet and outlining optimistic FY26 growth plans.

Pilbara Minerals reported a 4% rise in spodumene production and a 7% increase in sales for FY25 despite a 43% plunge in lithium prices, resulting in a statutory loss but maintaining robust cash reserves.